SynthesisFrontiers in immunology2024

Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: a systematic review and meta-analysis.

Guangwei Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.